A bill to amend the Public Health Service Act to improve the diagnosis and treatment of hereditary hemorrhagic telangiectasia, and for other purposes.
The bill’s titles are written by its sponsor.
Earlier Version — Introduced
This activity took place on a related bill, S. 1167 (112th).
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
S. 908 (113th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 113th Congress, which met from Jan 3, 2013 to Jan 2, 2015. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2017). S. 908 — 113th Congress: Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2013. Retrieved from https://www.govtrack.us/congress/bills/113/s908
“S. 908 — 113th Congress: Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2013.” www.GovTrack.us. 2013. July 24, 2017 <https://www.govtrack.us/congress/bills/113/s908>
|title=S. 908 (113th)
|accessdate=July 24, 2017
|author=113th Congress (2013)
|date=May 8, 2013
|quote=Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2013
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.